香雪製藥(300147.SZ)子公司擬1200萬元收購寶鼎公司40%出資額
格隆匯12月9日丨香雪製藥(300147.SZ)公佈,公司第八屆董事會第八次會議審議通過了《關於子公司收購化州市寶鼎化橘紅產業發展有限公司40%出資額的議案》,同意子公司廣東化州中藥廠製藥有限公司(“化州中藥廠”)以自有資金人民幣1200萬元收購化州市城市發展投資有限公司、茂名市耀明企業集團有限公司、化州市華聰藥業有限公司持有的化州市寶鼎化橘紅產業發展有限公司(“寶鼎公司”)40%出資額。收購完成後,化州中藥廠持有寶鼎公司100%股份,並按照寶鼎公司公司章程的規定及投資進程足額繳納註冊資本。
化州市寶鼎化橘紅產業發展有限公司經營範圍:化橘紅現代農業產業園區配套設施及旅遊景點的項目投資、建設、運營管理;化橘紅、化橘紅製品、農產品的展覽服務;化橘紅種植;加工、銷售:化橘紅製品、農產品;化橘紅品牌建設推廣、技術研發及信息諮詢服務;物業管理、租賃服務;貨物進出口及技術進出口(法律、行政法規禁止的項目不得經營,法律、行政法規限制的項目需取得許可後方可經營)。(依法須經批准的項目,經相關部門批准後方可開展經營活動)
公司致力於化橘紅研究並開發了以化橘紅為主要原料的橘紅系列中成藥,打造橘紅系列產品為主的中成藥製造、橘紅飲片精緻加工、倉儲物流為一體的新型生產加工基地。公司基於戰略佈局及長遠利益的考量實施此次交易,對業務結構進一步調整優化,有利於公司統一高效的運營管理,符合公司的發展需求和整體經營規劃,也有利於公司優化資產配置,做強公司主業。此次股權收購的資金來源均為子公司自籌資金,不會對公司的生產經營和業績帶來重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.